The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study

INTRODUCTION: Pegylated interferon-based therapy for hepatitis C virus (HCV) negatively impacts nutritional state and patient-reported outcomes (PROs) such as health-related quality of life (HRQL). Clinical trials with direct-acting antivirals (DAAs) report significant PRO improvement but real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Kracht, Patricia A. M., Lieveld, Faydra I., Amelung, Linde M., Verstraete, Carina J. R., Mauser-Bunschoten, Eveline P., de Bruijne, Joep, Siersema, Peter D., Hoepelman, Andy I. M., Arends, Joop E., van Erpecum, Karel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098748/
https://www.ncbi.nlm.nih.gov/pubmed/30076582
http://dx.doi.org/10.1007/s40121-018-0208-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098748/
https://www.ncbi.nlm.nih.gov/pubmed/30076582
http://dx.doi.org/10.1007/s40121-018-0208-z

Ejemplares similares